Single Point Partners’s Amgen AMGN Stock Holding History

Single Point Partners’s Portfolio AMGN Stock Details AMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-869	Closed	-$210K	–	73
2023 Q1	$210K	Buy	+869	New	+$213K	0.05%	146

Other funds holding AMGN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Single Point Partners's AMGN Position: Q2 2023 in Review

Single Point Partners sold out of Amgen (AMGN) in Q2 2023, closing a stake of 869 shares — an estimated $210K sold.

Single Point Partners first reported a position in AMGN in Q1 2023 and held it in 1 quarter. The position peaked at $210K in Q1 2023. 2,391 funds tracked by Wall St. Rank hold AMGN as of Q2 2023.

Single Point Partners reported no remaining Amgen position as of Q2 2023 after selling out during the quarter.
Single Point Partners sold 869 Amgen shares in Q2 2023, an estimated $210K.
Single Point Partners first reported a position in Amgen in Q1 2023 and held it in 1 quarter.
Single Point Partners's Amgen position peaked at $210K in Q1 2023.
2,391 funds tracked by Wall St. Rank held Amgen as of Q2 2023.

Based on Single Point Partners's 13F filing for Q2 2023, filed 10 Jul 2023.